Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
Melkersson
Kristina
K
Sollentuna Psychiatric Policlinic, Sollentuna Hospital, Stockholm, Sweden.
Hulting
Anna-Lena
AL
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D003920:Diabetes Mellitus / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D018967:Risperidone / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine; D010890:Pirenzepine; D018967:Risperidone; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors